Article

Impact of Continuous Erythropoietin Receptor Activator on Selected Biomarkers of…

Oxidative Medicine and Cellular Longevity · 2015 · Piotr Bartnicki, author Jacek Rysz, author Beata Franczyk, author Zbigniew Baj, author Ewa Majewska, author Aramati B. M. Reddy, Academic Editor

Key facts

Title Impact of Continuous Erythropoietin Receptor Activator on Selected Biomarkers of Cardiovascular Disease and Left Ventricle Structure and Function in Chronic Kidney Disease
First author Piotr Bartnicki, author Jacek Rysz, author Beata Franczyk, author Zbigniew Baj, author Ewa Majewska, author Aramati B. M. Reddy, Academic Editor
Journal Oxidative Medicine and Cellular Longevity
Published Nov 25, 2015
DOI 10.1155/2016/9879615
Devices mentioned 008720, K080176, K093488, K122341, K123828, K140639, K162583
Product codes mentioned IYN, IYO

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature